AI assistant
Sending…
Sanara MedTech Inc. — Director's Dealing 2023
Sep 22, 2023
33339_dirs_2023-09-22_8d0f53cb-974e-4657-b0f1-4d9efdc000c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2023-09-21
Reporting Person: Fleming Zachary B. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-21 | Common Stock | F | 684 | $37.19 | Disposed | 39559 | Direct |
Footnotes
F1: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,736 shares of restricted stock
granted to the reporting person on March 2, 2023. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the
shares vested as reported on the Nasdaq Capital Market.
More from Sanara MedTech Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Major Shareholding Notification
2026
Apr 14
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 23